Trial Outcomes & Findings for Neurocognitive and Neurobiological Improvement in ADHD Children by Modification of Dietary Protein (NCT NCT01856686)

NCT ID: NCT01856686

Last Updated: 2024-05-08

Results Overview

Reaction time during visual continuous performance task from 19 channels EEG recordings, after 3 months of dietary approach.

Recruitment status

COMPLETED

Study phase

EARLY_PHASE1

Target enrollment

64 participants

Primary outcome timeframe

3 months

Results posted on

2024-05-08

Participant Flow

Participant milestones

Participant milestones
Measure
BP22042013
This group of patients receive 2.000 kilocalories diet(60 g. carbohydrates, 144 gr of fat and 107 gr of proteins), including 2 protein shakes.
Low Carbohydrate Diet
This group of patients receive diet of 2.000 Kilo-calories without rapidly absorbed carbohydrates and without proteins supplements
Overall Study
STARTED
31
33
Overall Study
COMPLETED
26
22
Overall Study
NOT COMPLETED
5
11

Reasons for withdrawal

Reasons for withdrawal
Measure
BP22042013
This group of patients receive 2.000 kilocalories diet(60 g. carbohydrates, 144 gr of fat and 107 gr of proteins), including 2 protein shakes.
Low Carbohydrate Diet
This group of patients receive diet of 2.000 Kilo-calories without rapidly absorbed carbohydrates and without proteins supplements
Overall Study
Lost to Follow-up
5
11

Baseline Characteristics

Neurocognitive and Neurobiological Improvement in ADHD Children by Modification of Dietary Protein

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
BP22042013
n=26 Participants
This group of patients receive 2.000 kilocalories diet(60 g. carbohydrates, 144 gr of fat and 107 gr of proteins), including 2 protein shakes. BP22042013: This group of patients receive 2.000 kilo-calories diet (60 g. carbohydrates, 144 gr of fat and 107 gr of proteins), including 2 protein shakes.
Low Carbohydrate Diet
n=22 Participants
the second group of patients receive diet of 2.000 Kilo calories without rapidly absorbed carbohydrates and without proteins supplements Low carbohydrate diet: the second group of patients receive diet of 2.000 Kilo-calories without rapidly absorbed carbohydrates and without proteins supplements
Total
n=48 Participants
Total of all reporting groups
Age, Continuous
9.08 years
STANDARD_DEVIATION 1.9 • n=5 Participants
9.41 years
STANDARD_DEVIATION 1.87 • n=7 Participants
9.23 years
STANDARD_DEVIATION 1.87 • n=5 Participants
Sex: Female, Male
Female
10 Participants
n=5 Participants
8 Participants
n=7 Participants
18 Participants
n=5 Participants
Sex: Female, Male
Male
16 Participants
n=5 Participants
14 Participants
n=7 Participants
30 Participants
n=5 Participants
Reaction time
520.46 milliseconds
STANDARD_DEVIATION 93.27 • n=5 Participants
506.59 milliseconds
STANDARD_DEVIATION 65.74 • n=7 Participants
514.10 milliseconds
STANDARD_DEVIATION 81.28 • n=5 Participants
Omission errors
19.31 errors
STANDARD_DEVIATION 20.69 • n=5 Participants
18.00 errors
STANDARD_DEVIATION 15.39 • n=7 Participants
18.71 errors
STANDARD_DEVIATION 18.28 • n=5 Participants
Comission errors
4.58 errors
STANDARD_DEVIATION 6.30 • n=5 Participants
2.82 errors
STANDARD_DEVIATION 2.79 • n=7 Participants
3.77 errors
STANDARD_DEVIATION 5.04 • n=5 Participants
Occipital alpha waves-frequency
9.62 Hz
STANDARD_DEVIATION 1.02 • n=5 Participants
9.48 Hz
STANDARD_DEVIATION 0.99 • n=7 Participants
9.55 Hz
STANDARD_DEVIATION 1.00 • n=5 Participants
Occipital alpha waves-amplitude
15.75 microvolts
STANDARD_DEVIATION 10.45 • n=5 Participants
20.56 microvolts
STANDARD_DEVIATION 17.02 • n=7 Participants
17.95 microvolts
STANDARD_DEVIATION 13.90 • n=5 Participants
Parietal alpha waves-frequency
8.72 Hertz
STANDARD_DEVIATION 1.04 • n=5 Participants
9.12 Hertz
STANDARD_DEVIATION 0.94 • n=7 Participants
8.91 Hertz
STANDARD_DEVIATION 1.00 • n=5 Participants
Mu wave frequency
9.07 Hertz
STANDARD_DEVIATION 1.22 • n=5 Participants
9.09 Hertz
STANDARD_DEVIATION 1.06 • n=7 Participants
9.08 Hertz
STANDARD_DEVIATION 1.14 • n=5 Participants
Mu waves-amplitude
7.38 microvolts
STANDARD_DEVIATION 6.77 • n=5 Participants
7.87 microvolts
STANDARD_DEVIATION 8.09 • n=7 Participants
7.60 microvolts
STANDARD_DEVIATION 7.33 • n=5 Participants
Frontal midline theta activity- frequency
4.69 Hertz
STANDARD_DEVIATION 1.13 • n=5 Participants
4.88 Hertz
STANDARD_DEVIATION 1.40 • n=7 Participants
4.78 Hertz
STANDARD_DEVIATION 1.25 • n=5 Participants
Frontal midline theta activity- amplitude
8.08 microvolts
STANDARD_DEVIATION 5.87 • n=5 Participants
11.66 microvolts
STANDARD_DEVIATION 8.17 • n=7 Participants
9.72 microvolts
STANDARD_DEVIATION 7.17 • n=5 Participants
Monastra ratio
22.15 ratio
STANDARD_DEVIATION 8.75 • n=5 Participants
25.14 ratio
STANDARD_DEVIATION 9.72 • n=7 Participants
23.52 ratio
STANDARD_DEVIATION 9.23 • n=5 Participants
weight
30.09 Kilograms
STANDARD_DEVIATION 7.66 • n=5 Participants
38.15 Kilograms
STANDARD_DEVIATION 11.36 • n=7 Participants
33.78 Kilograms
STANDARD_DEVIATION 10.26 • n=5 Participants
Body mass index
16.16 kg/m2
STANDARD_DEVIATION 2.87 • n=5 Participants
18.77 kg/m2
STANDARD_DEVIATION 3.66 • n=7 Participants
17.36 kg/m2
STANDARD_DEVIATION 3.48 • n=5 Participants
Hyperactivity score (clinical scale)
3.62 units on a scale
STANDARD_DEVIATION 2.59 • n=5 Participants
3.82 units on a scale
STANDARD_DEVIATION 2.67 • n=7 Participants
3.71 units on a scale
STANDARD_DEVIATION 2.60 • n=5 Participants
Impulsivity score (clinical scale)
4.58 units on a scale
STANDARD_DEVIATION 2.42 • n=5 Participants
4.82 units on a scale
STANDARD_DEVIATION 2.74 • n=7 Participants
4.69 units on a scale
STANDARD_DEVIATION 2.54 • n=5 Participants
Inattention score (clinical score)
7.69 units on a scale
STANDARD_DEVIATION 1.52 • n=5 Participants
7.91 units on a scale
STANDARD_DEVIATION 1.60 • n=7 Participants
7.79 units on a scale
STANDARD_DEVIATION 1.54 • n=5 Participants
Behavior (clinical scale)
15.88 units on a scale
STANDARD_DEVIATION 4.95 • n=5 Participants
16.55 units on a scale
STANDARD_DEVIATION 5.76 • n=7 Participants
16.19 units on a scale
STANDARD_DEVIATION 5.29 • n=5 Participants

PRIMARY outcome

Timeframe: 3 months

Reaction time during visual continuous performance task from 19 channels EEG recordings, after 3 months of dietary approach.

Outcome measures

Outcome measures
Measure
BP22042013
n=26 Participants
This group of patients receive 2.000 kilocalories diet(60 g. carbohydrates, 144 gr of fat and 107 gr of proteins), including 2 protein shakes. BP22042013: This group of patients receive 2.000 kilo-calories diet (60 g. carbohydrates, 144 gr of fat and 107 gr of proteins), including 2 protein shakes.
Low Carbohydrate Diet
n=22 Participants
the second group of patients receive diet of 2.000 Kilo calories without rapidly absorbed carbohydrates and without proteins supplements Low carbohydrate diet: the second group of patients receive diet of 2.000 Kilo-calories without rapidly absorbed carbohydrates and without proteins supplements
Reaction Time at 3 Months
506.58 milliseconds
Standard Deviation 108.72
510.59 milliseconds
Standard Deviation 99.05

PRIMARY outcome

Timeframe: 3 months

Omission errors during visual continuous performance task from 19 channels EEG recordings, after 3 months of dietary approach. (Test duration: 22 minutes)

Outcome measures

Outcome measures
Measure
BP22042013
n=26 Participants
This group of patients receive 2.000 kilocalories diet(60 g. carbohydrates, 144 gr of fat and 107 gr of proteins), including 2 protein shakes. BP22042013: This group of patients receive 2.000 kilo-calories diet (60 g. carbohydrates, 144 gr of fat and 107 gr of proteins), including 2 protein shakes.
Low Carbohydrate Diet
n=22 Participants
the second group of patients receive diet of 2.000 Kilo calories without rapidly absorbed carbohydrates and without proteins supplements Low carbohydrate diet: the second group of patients receive diet of 2.000 Kilo-calories without rapidly absorbed carbohydrates and without proteins supplements
Omission Errors at 3 Months
17.15 errors
Standard Deviation 19.54
14.95 errors
Standard Deviation 13.43

PRIMARY outcome

Timeframe: 3 months

comission errors during visual continuous performance task from 19 channels EEG recordings, after 3 months of dietary approach.(Test duration: 22 minutes)

Outcome measures

Outcome measures
Measure
BP22042013
n=26 Participants
This group of patients receive 2.000 kilocalories diet(60 g. carbohydrates, 144 gr of fat and 107 gr of proteins), including 2 protein shakes. BP22042013: This group of patients receive 2.000 kilo-calories diet (60 g. carbohydrates, 144 gr of fat and 107 gr of proteins), including 2 protein shakes.
Low Carbohydrate Diet
n=22 Participants
the second group of patients receive diet of 2.000 Kilo calories without rapidly absorbed carbohydrates and without proteins supplements Low carbohydrate diet: the second group of patients receive diet of 2.000 Kilo-calories without rapidly absorbed carbohydrates and without proteins supplements
Comission Errors at 3 Months
2.19 errors
Standard Deviation 3.38
2.82 errors
Standard Deviation 4.05

PRIMARY outcome

Timeframe: 3 months

occipital alpha waves amplitudes during visual continuous performance task from 19 channels EEG recordings, after 3 months of dietary approach.

Outcome measures

Outcome measures
Measure
BP22042013
n=26 Participants
This group of patients receive 2.000 kilocalories diet(60 g. carbohydrates, 144 gr of fat and 107 gr of proteins), including 2 protein shakes. BP22042013: This group of patients receive 2.000 kilo-calories diet (60 g. carbohydrates, 144 gr of fat and 107 gr of proteins), including 2 protein shakes.
Low Carbohydrate Diet
n=22 Participants
the second group of patients receive diet of 2.000 Kilo calories without rapidly absorbed carbohydrates and without proteins supplements Low carbohydrate diet: the second group of patients receive diet of 2.000 Kilo-calories without rapidly absorbed carbohydrates and without proteins supplements
Occipital Alpha Brainwaves Amplitudes at 3 Months
12.25 microvolts
Standard Deviation 9.89
11.99 microvolts
Standard Deviation 11.24

PRIMARY outcome

Timeframe: 3 months

Mu waves-amplitude during visual continuous performance task from 19 channels EEG recordings, after 3 months of dietary approach.

Outcome measures

Outcome measures
Measure
BP22042013
n=26 Participants
This group of patients receive 2.000 kilocalories diet(60 g. carbohydrates, 144 gr of fat and 107 gr of proteins), including 2 protein shakes. BP22042013: This group of patients receive 2.000 kilo-calories diet (60 g. carbohydrates, 144 gr of fat and 107 gr of proteins), including 2 protein shakes.
Low Carbohydrate Diet
n=22 Participants
the second group of patients receive diet of 2.000 Kilo calories without rapidly absorbed carbohydrates and without proteins supplements Low carbohydrate diet: the second group of patients receive diet of 2.000 Kilo-calories without rapidly absorbed carbohydrates and without proteins supplements
Mu Waves-amplitude at 3 Months
6.32 microvolts
Standard Deviation 6.38
6.05 microvolts
Standard Deviation 5.59

PRIMARY outcome

Timeframe: 3 months

Frontal midline theta activity- amplitude during visual continuous performance task from 19 channels EEG recordings, after 3 months of dietary approach.

Outcome measures

Outcome measures
Measure
BP22042013
n=26 Participants
This group of patients receive 2.000 kilocalories diet(60 g. carbohydrates, 144 gr of fat and 107 gr of proteins), including 2 protein shakes. BP22042013: This group of patients receive 2.000 kilo-calories diet (60 g. carbohydrates, 144 gr of fat and 107 gr of proteins), including 2 protein shakes.
Low Carbohydrate Diet
n=22 Participants
the second group of patients receive diet of 2.000 Kilo calories without rapidly absorbed carbohydrates and without proteins supplements Low carbohydrate diet: the second group of patients receive diet of 2.000 Kilo-calories without rapidly absorbed carbohydrates and without proteins supplements
Frontal Midline Theta Activity- Amplitude at 3 Months
6.81 microvolts
Standard Deviation 3.62
9.13 microvolts
Standard Deviation 7.30

SECONDARY outcome

Timeframe: 3 months

occipital alpha waves-frequency during visual continuous performance task from 19 channels EEG recordings, after 3 months of dietary approach.

Outcome measures

Outcome measures
Measure
BP22042013
n=26 Participants
This group of patients receive 2.000 kilocalories diet(60 g. carbohydrates, 144 gr of fat and 107 gr of proteins), including 2 protein shakes. BP22042013: This group of patients receive 2.000 kilo-calories diet (60 g. carbohydrates, 144 gr of fat and 107 gr of proteins), including 2 protein shakes.
Low Carbohydrate Diet
n=22 Participants
the second group of patients receive diet of 2.000 Kilo calories without rapidly absorbed carbohydrates and without proteins supplements Low carbohydrate diet: the second group of patients receive diet of 2.000 Kilo-calories without rapidly absorbed carbohydrates and without proteins supplements
Occipital Alpha Waves-frequency at 3 Months
9.71 Hz
Standard Deviation 1.13
9.60 Hz
Standard Deviation 1.24

SECONDARY outcome

Timeframe: 3 months

Parietal alpha waves-frequency during visual continuous performance task from 19 channels EEG recordings, after 3 months of dietary approach.

Outcome measures

Outcome measures
Measure
BP22042013
n=26 Participants
This group of patients receive 2.000 kilocalories diet(60 g. carbohydrates, 144 gr of fat and 107 gr of proteins), including 2 protein shakes. BP22042013: This group of patients receive 2.000 kilo-calories diet (60 g. carbohydrates, 144 gr of fat and 107 gr of proteins), including 2 protein shakes.
Low Carbohydrate Diet
n=22 Participants
the second group of patients receive diet of 2.000 Kilo calories without rapidly absorbed carbohydrates and without proteins supplements Low carbohydrate diet: the second group of patients receive diet of 2.000 Kilo-calories without rapidly absorbed carbohydrates and without proteins supplements
Parietal Alpha Waves-frequency at 3 Months
8.96 Hz
Standard Deviation 1.09
9.21 Hz
Standard Deviation 1.07

SECONDARY outcome

Timeframe: 3 months

Mu wave frequency during visual continuous performance task from 19 channels EEG recordings, after 3 months of dietary approach.

Outcome measures

Outcome measures
Measure
BP22042013
n=26 Participants
This group of patients receive 2.000 kilocalories diet(60 g. carbohydrates, 144 gr of fat and 107 gr of proteins), including 2 protein shakes. BP22042013: This group of patients receive 2.000 kilo-calories diet (60 g. carbohydrates, 144 gr of fat and 107 gr of proteins), including 2 protein shakes.
Low Carbohydrate Diet
n=22 Participants
the second group of patients receive diet of 2.000 Kilo calories without rapidly absorbed carbohydrates and without proteins supplements Low carbohydrate diet: the second group of patients receive diet of 2.000 Kilo-calories without rapidly absorbed carbohydrates and without proteins supplements
Mu Wave Frequency at 3 Months
9.06 Hz
Standard Deviation 1.13
9.07 Hz
Standard Deviation 1.17

SECONDARY outcome

Timeframe: 3 months

Frontal midline theta activity- frequency during visual continuous performance task from 19 channels EEG recordings, after 3 months of dietary approach.

Outcome measures

Outcome measures
Measure
BP22042013
n=26 Participants
This group of patients receive 2.000 kilocalories diet(60 g. carbohydrates, 144 gr of fat and 107 gr of proteins), including 2 protein shakes. BP22042013: This group of patients receive 2.000 kilo-calories diet (60 g. carbohydrates, 144 gr of fat and 107 gr of proteins), including 2 protein shakes.
Low Carbohydrate Diet
n=22 Participants
the second group of patients receive diet of 2.000 Kilo calories without rapidly absorbed carbohydrates and without proteins supplements Low carbohydrate diet: the second group of patients receive diet of 2.000 Kilo-calories without rapidly absorbed carbohydrates and without proteins supplements
Frontal Midline Theta Activity- Frequency at 3 Months
4.70 Hz
Standard Deviation 1.38
4.76 Hz
Standard Deviation 1.30

SECONDARY outcome

Timeframe: 3 months

Monastra ratio during visual continuous performance task from 19 channels EEG recordings, after 3 months of dietary approach.

Outcome measures

Outcome measures
Measure
BP22042013
n=26 Participants
This group of patients receive 2.000 kilocalories diet(60 g. carbohydrates, 144 gr of fat and 107 gr of proteins), including 2 protein shakes. BP22042013: This group of patients receive 2.000 kilo-calories diet (60 g. carbohydrates, 144 gr of fat and 107 gr of proteins), including 2 protein shakes.
Low Carbohydrate Diet
n=22 Participants
the second group of patients receive diet of 2.000 Kilo calories without rapidly absorbed carbohydrates and without proteins supplements Low carbohydrate diet: the second group of patients receive diet of 2.000 Kilo-calories without rapidly absorbed carbohydrates and without proteins supplements
Monastra Ratio at 3 Months
16.88 ratio
Standard Deviation 9.84
22.36 ratio
Standard Deviation 11.27

SECONDARY outcome

Timeframe: 3 months

Behavior assessed by total score of clinical questionnaire (sum of Hyperactivity, Impulsivity and Inattention scores), after 3 months of nutritional approach. Range: minimum value: 0 and maximum value: 25. Higher values represent a worse outcome.

Outcome measures

Outcome measures
Measure
BP22042013
n=26 Participants
This group of patients receive 2.000 kilocalories diet(60 g. carbohydrates, 144 gr of fat and 107 gr of proteins), including 2 protein shakes. BP22042013: This group of patients receive 2.000 kilo-calories diet (60 g. carbohydrates, 144 gr of fat and 107 gr of proteins), including 2 protein shakes.
Low Carbohydrate Diet
n=22 Participants
the second group of patients receive diet of 2.000 Kilo calories without rapidly absorbed carbohydrates and without proteins supplements Low carbohydrate diet: the second group of patients receive diet of 2.000 Kilo-calories without rapidly absorbed carbohydrates and without proteins supplements
Behavior
13.08 units on a scale
Standard Deviation 5.11
12.45 units on a scale
Standard Deviation 5.87

SECONDARY outcome

Timeframe: 3 months

Hyperactivity assessed by clinical questionnaire after 3 months of nutritional approach. Range: minimum value: 0 and maximum value: 8. Higher values represent a worse outcome.

Outcome measures

Outcome measures
Measure
BP22042013
n=26 Participants
This group of patients receive 2.000 kilocalories diet(60 g. carbohydrates, 144 gr of fat and 107 gr of proteins), including 2 protein shakes. BP22042013: This group of patients receive 2.000 kilo-calories diet (60 g. carbohydrates, 144 gr of fat and 107 gr of proteins), including 2 protein shakes.
Low Carbohydrate Diet
n=22 Participants
the second group of patients receive diet of 2.000 Kilo calories without rapidly absorbed carbohydrates and without proteins supplements Low carbohydrate diet: the second group of patients receive diet of 2.000 Kilo-calories without rapidly absorbed carbohydrates and without proteins supplements
Hyperactivity Score
3.04 units on a scale
Standard Deviation 2.39
2.68 units on a scale
Standard Deviation 2.25

SECONDARY outcome

Timeframe: 3 months

Impulsivity assessed by clinical questionnaire after 3 months of nutritional approach. Range: minimum value: 0 and maximum value: 8. Higher values represent a worse outcome.

Outcome measures

Outcome measures
Measure
BP22042013
n=26 Participants
This group of patients receive 2.000 kilocalories diet(60 g. carbohydrates, 144 gr of fat and 107 gr of proteins), including 2 protein shakes. BP22042013: This group of patients receive 2.000 kilo-calories diet (60 g. carbohydrates, 144 gr of fat and 107 gr of proteins), including 2 protein shakes.
Low Carbohydrate Diet
n=22 Participants
the second group of patients receive diet of 2.000 Kilo calories without rapidly absorbed carbohydrates and without proteins supplements Low carbohydrate diet: the second group of patients receive diet of 2.000 Kilo-calories without rapidly absorbed carbohydrates and without proteins supplements
Impulsivity Score
3.96 units on a scale
Standard Deviation 2.16
3.55 units on a scale
Standard Deviation 2.22

SECONDARY outcome

Timeframe: 3 months

Inattention assessed by clinical questionnaire after 3 months of nutritional approach. Range: minimum value: 0 and maximum value: 9. Higher values represent a worse outcome.

Outcome measures

Outcome measures
Measure
BP22042013
n=26 Participants
This group of patients receive 2.000 kilocalories diet(60 g. carbohydrates, 144 gr of fat and 107 gr of proteins), including 2 protein shakes. BP22042013: This group of patients receive 2.000 kilo-calories diet (60 g. carbohydrates, 144 gr of fat and 107 gr of proteins), including 2 protein shakes.
Low Carbohydrate Diet
n=22 Participants
the second group of patients receive diet of 2.000 Kilo calories without rapidly absorbed carbohydrates and without proteins supplements Low carbohydrate diet: the second group of patients receive diet of 2.000 Kilo-calories without rapidly absorbed carbohydrates and without proteins supplements
Inattention Score
6.08 units on a scale
Standard Deviation 2.50
6.23 units on a scale
Standard Deviation 2.43

OTHER_PRE_SPECIFIED outcome

Timeframe: 3 months

Weight after 3 months of dietary approach.

Outcome measures

Outcome measures
Measure
BP22042013
n=26 Participants
This group of patients receive 2.000 kilocalories diet(60 g. carbohydrates, 144 gr of fat and 107 gr of proteins), including 2 protein shakes. BP22042013: This group of patients receive 2.000 kilo-calories diet (60 g. carbohydrates, 144 gr of fat and 107 gr of proteins), including 2 protein shakes.
Low Carbohydrate Diet
n=22 Participants
the second group of patients receive diet of 2.000 Kilo calories without rapidly absorbed carbohydrates and without proteins supplements Low carbohydrate diet: the second group of patients receive diet of 2.000 Kilo-calories without rapidly absorbed carbohydrates and without proteins supplements
Weight at 3 Months
31.59 kilograms
Standard Deviation 7.28
38.67 kilograms
Standard Deviation 11.18

OTHER_PRE_SPECIFIED outcome

Timeframe: 3 months

Body mass index after 3 months of dietary approach.

Outcome measures

Outcome measures
Measure
BP22042013
n=26 Participants
This group of patients receive 2.000 kilocalories diet(60 g. carbohydrates, 144 gr of fat and 107 gr of proteins), including 2 protein shakes. BP22042013: This group of patients receive 2.000 kilo-calories diet (60 g. carbohydrates, 144 gr of fat and 107 gr of proteins), including 2 protein shakes.
Low Carbohydrate Diet
n=22 Participants
the second group of patients receive diet of 2.000 Kilo calories without rapidly absorbed carbohydrates and without proteins supplements Low carbohydrate diet: the second group of patients receive diet of 2.000 Kilo-calories without rapidly absorbed carbohydrates and without proteins supplements
Body Mass Index at 3 Months
16.50 kg/m2
Standard Deviation 2.54
18.55 kg/m2
Standard Deviation 3.43

OTHER_PRE_SPECIFIED outcome

Timeframe: Up to 8 months

Number of Participants with Adverse Events as a Measure of Safety and Tolerability of Brain Proteins Supplements

Outcome measures

Outcome measures
Measure
BP22042013
n=26 Participants
This group of patients receive 2.000 kilocalories diet(60 g. carbohydrates, 144 gr of fat and 107 gr of proteins), including 2 protein shakes. BP22042013: This group of patients receive 2.000 kilo-calories diet (60 g. carbohydrates, 144 gr of fat and 107 gr of proteins), including 2 protein shakes.
Low Carbohydrate Diet
n=22 Participants
the second group of patients receive diet of 2.000 Kilo calories without rapidly absorbed carbohydrates and without proteins supplements Low carbohydrate diet: the second group of patients receive diet of 2.000 Kilo-calories without rapidly absorbed carbohydrates and without proteins supplements
Number of Participants With Adverse Events as a Measure of Safety and Tolerability
0 participants
0 participants

Adverse Events

BP22042013

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Low Carbohydrate Diet

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Moises Aguilar Domingo

Spanish Foundation for Neurometrics Development

Phone: +441615312645

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place